No. | Initial PET/CT scan | Follow-up PET/CT scana | ||||||
---|---|---|---|---|---|---|---|---|
FBG (mg/dL) | Uptake sitesb | Visual scores | SUVmaxc | FBG (mg/dL) | Visual scores | SUVmaxc | Interval (months) | |
1 | 101 | 1/2//3/4 | 3/3//3/3 | 5.8/5.7/3.6/5.1 | 116 | 3/3/1/3 | 3.1/2.7/−/2.7 | 3 |
2 | 89 | 1/2/3/4/5/6/7 | 3/3/3/3/3/3/3 | 3.8/3.7/4.0/3.9/4.0/3.8/3.7 | 101 | 2/2/2/0/3/0/0 | 2.0/2.1/2.1/−/3.1/−/− | 3 |
3 | 83 | 2/3/4/6/7/8 | 3/3/3/3/3/3 | 4.4/4.2/3.8/3.8/3.8/4.8 | 98 | 3/0/3/3/3/3 | 3.8/−/3.0/3.0/3.0/3.0 | 2.5 |
4 | 93 | 6 | 3 | 3.6 | ||||
5 | 93 | 1/3/8/9 | 3/3/3/3 | 3.3/4.2/4.5/5.0 | 89 | 2/0/3/3 | 2.1/−/3.0/2.8 | 3 |
6 | 115 | 1/8 | 3/3 | 3.5/4.2 | 108 | 3/0 | 2.8/− | 4 |
7 | 85 | – | – | – | ||||
8 | 116 | 1/9 | 3/3 | 3.9/2.5 | ||||
9 | 88 | 1/9/10 | 3/3/3 | 3.3/4.5/4.3 | ||||
10 | 79 | 1/10 | 3/3 | 3.1/4.3 | ||||
11 | 112 | 1/8 | 3/3 | 3.3/3.8 | ||||
12 | 101 | 1/3/8/11 | 3/3/3/3 | 5.9/2.8/3.2/5.7 | 121 | 3/0/0/2 | 2.8/−/−/2.0 | 3 |
13 | 122 | 10 | 3 | 4.0 | ||||
14 | 99 | 1/2 | 3/3 | 3.4/3.8 | ||||
15 | 87 | 1/2/8/10 | 3/3/3/3 | 3.8/4.9/4.9/3.5 | ||||
16 | 110 | 1/2/3/9/10 | 3/3/3/3/3 | 2.5/2.6/2.2/4.7/2.6 | ||||
17 | 95 | 1/2/8/12 | 1/3/3/3 | −/6.2/3.2/2.7 | 113 | 0/2/0/0 | −/3.0/−/− | 4 |
18 | 123 | 1/2/8/10 | 1/2/3/3 | −/1.9/3.0/2.2 | ||||
19 | 101 | 1/2/8/10 | 3/3/3/3 | 2.7/3.7/3.0/5.5 | ||||
20 | 111 | 1/2/4/8/10 | 3/3/3/3/3 | 3.2/3.2/4.2/4.0/4.2 | 110 | 0/3/0/2/0 | −/3.9/−/2.0/− | 3 |
21 | 121 | 1 | 3 | 2.0 | ||||
22 | 96 | 1/2/9 | 3/1/3 | 3.8/−/6.4 | ||||
23 | 88 | 1/2/3/8/9/10 | 3/3/3/3/3/3 | 3.7/3.0/4.5/3.5/3.5/3.2 | ||||
24 | 99 | 1/2/3/8/10 | 3/3/3/3/3 | 3.8/2.7/8.1/3.6/7.2 | 103 | 0/0/0/3/0 | −/−/−/4.2/− | 4 |
25 | 78 | 1/2/3/8 | 3/3/3/3/3 | 2.2/3.3/4.0/4.3 | ||||
26 | 108 | 1/2/3/8/10 | 3/2/3/2/3 | 4.8/1.8/2.8/1.7/3.8 | ||||
27 | 97 | 1/2/8/10 | 3/3/3/3 | 4.0/2.9/3.9/4.9 | 102 | 0/0/1/3 | −/−/1.2/2.8 | 3 |
28 | 87 | 1/2/13 | 3/3/3 | 9.1/4.9/17.9 | ||||
29 | 98 | 1 | 2 | 2.0 | ||||
30 | 102 | 1/2/3/9/10 | 3/3/3/3/3 | 4.6/3.2/4.5/4.7/5.0 |